Skip to content

All-optical synaptic electrophysiology probes mechanism of ketamine-induced disinhibition.

Linlin Z Fan, Ralda Nehme, Yoav Adam, Eun Sun Jung, Hao Wu, Kevin Eggan, Don B Arnold, Adam E Cohen

Nature Methods October 2018 DOI: 10.1038/s41592-018-0142-8 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Preclinical experimental study (in vitro and acute brain slice) Peer reviewed
Population Cultured rodent neurons and acute rodent brain slices
Intervention Ketamine
Topics Esketamine Ketamine
Key findings The authors report that synOptopatch enables all-optical recording of excitatory and inhibitory postsynaptic potentials in rodent neurons and slices. In primary rodent cultures, acute ketamine suppressed disynaptic inhibitory feedback, an effect the authors localize to excitatory synapses onto interneurons, and they propose this as an in vitro model of disynaptic disinhibition.

Abstract

Optical assays of synaptic strength could facilitate studies of neuronal transmission and its dysregulation in disease. Here we introduce a genetic toolbox for all-optical interrogation of synaptic electrophysiology (synOptopatch) via mutually exclusive expression of a channelrhodopsin actuator and an archaerhodopsin-derived voltage indicator. Optically induced activity in the channelrhodopsin-expressing neurons generated excitatory and inhibitory postsynaptic potentials that we optically resolved in reporter-expressing neurons. We further developed a yellow spine-targeted Ca2+ indicator to localize optogenetically triggered synaptic inputs. We demonstrated synOptopatch recordings in cultured rodent neurons and in acute rodent brain slice. In synOptopatch measurements of primary rodent cultures, acute ketamine administration suppressed disynaptic inhibitory feedbacks, mimicking the effect of this drug on network function in both rodents and humans. We localized this action of ketamine to excitatory synapses onto interneurons. These results establish an in vitro all-optical model of disynaptic disinhibition, a synaptic defect hypothesized in schizophrenia-associated psychosis.

Comparable studies

Other preclinical and animal studies on ketamine, most cited first.

Citations in the library

Explore topics